Cardiovascular disease (CVD) risk in individuals with metabolically healthy obesity (MHO)
is unclear. We searched databases from inception to May 2019. Data were pooled using a …

METHODS Participants who attended the smoking cessation program in an outpatient clinic
of a tertiary medical center in Taiwan from 2017 to 2018 were enrolled in this retrospective …

We investigated the association among metabolically healthy obesity (MHO), cardiovascular
disease (CVD)risk, and all-cause mortality in the Asian population. We searched databases …

Background This research aimed to investigate the associations of anthropometric
measurements, physiological parameters, chronic disease comorbidities, and social and lifestyle …

Background Metabolically healthy obesity (MHO) is defined as obesity with less than two
parameters of metabolic abnormalities. Some studies report that MHO individuals show similar …

Osteopoikilosis is a benign but rare condition characterized by bone islands throughout the
osseous tissue, which could be easily confused with bone metastasis. We present a case of …

Hypertrophic cardiomyopathy (HCM) is an often under-diagnosed cause of left ventricular
hypertrophy (LVH). It affects 1/500 of the population, is the most commonly inherited …

Background This study assessed the associations of metabolic obesity phenotypes with the
risk of atrial fibrillation (Afib). Methods This prospective cohort study categorized Taiwanese …

Purpose Dynamic 18 F-fluorodeoxyglucose (FDG) PET can be used to quantitatively assess
the rate of myocardial glucose uptake (MRGlu). The aim of this study was to evaluate the …

To determine the clinical value of radionuclide shuntography in the evaluation of adult
hydrocephalic patients with suspected ventriculoperitoneal (VP) shunt malfunction. All adult …